Traduction de «phase-specific » (Anglais → Français) :

specification phase [ specification stage | product specification stage | product specification phase | project requirements stage | project requirements phase | design requirements phase | design requirements stage ]

Definition: Fears in childhood that show a marked developmental phase specificity and arise (to some extent) in a majority of children, but that are abnormal in degree. Other fears that arise in childhood but that are not a normal part of psychosocial development (for example agoraphobia) should be coded under the appropriate category in section F40-F48.

gene action | cell specific | phase-specific

Workshop on ESCAP Regional Specifications for phase VI of the International Comparison Programme

Definition: The main feature is a specific and significant impairment in the development of reading skills that is not solely accounted for by mental age, visual acuity problems, or inadequate schooling. Reading comprehension skill, reading word recognition, oral reading skill, and performance of tasks requiring reading may all be affected. Spelling difficulties are frequently associated with specific reading disorder and often remain into adolescence even after some progress in reading has been made. Specific developmental disorders of reading are commonly preceded by a history of disorders in speech or language development. Associated ...[+++]emotional and behavioural disturbances are common during the school age period. | Backward reading Developmental dyslexia Specific reading retardation

Definition: The main feature is a specific and significant impairment in the development of spelling skills in the absence of a history of specific reading disorder, which is not solely accounted for by low mental age, visual acuity problems, or inadequate schooling. The ability to spell orally and to write out words correctly are both affected. | Specific spelling retardation (without reading disorder)

Rare childhood-onset epilepsy syndrome associated with infection and a biphasic clinical course. The initial symptom is a prolonged febrile seizure on day 1 (the first phase). Afterwards, patients have variable levels of consciousness from normal to

Cryogenic laboratory freezer, vapor-phase nitrogen

Intervention" refers to comprehensive, intensive, phase-specific and individualized treatment plans for these individuals.

(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " major complications associated with venous angioplasty" have occurred in Canada and, if it is not possible ...[+++]to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...

(Return tabled) Question No. 848 Mr. Matthew Kellway: With regard to the National Shipbuilding Procurement Strategy (NSPS): (a) has a statement of operational requirements been established, (i) if yes, when was this done and what are the criteria that will be used to determine what ships will be built, (ii) if no, when will it be done, (iii) if it will not be done, what criteria will be used to determine what ships will be built; (b) will there be an open competition for contracts associated with the strategy; (c) what is a current breakdown of the $35 billion contract value that was assessed, specifically, what is the value of each individual component included in this assessed value; (d) where will the technology being used to build th ...[+++]e ships come from; (e) what components will be included in each ship (i.e., hull, weapons systems, propulsion, etc.); (f) will the ships have all components necessary for deployment, (i) if not, why not and which components will need to be procured at a future date, (ii) if yes, what contracts have been signed that to account for this answer; (g) how will the contracts be awarded, specifying (i) how many ships will be built, (ii) which shipyards will be used for construction, (iii) what will be the dollar value of contracts awarded to each of the shipyards; (h) what are the details of any changes the government has made to the strategy and associated contracts as a result of delays in delivery (for example, in the case of the Arctic/Offshore Patrol Ships (AOPS)) and what are the impacts of the delays in delivery on the overall cost of the project, identifying in particular whether and how delays have impacted the estimated $3.1 billion cost of the AOPS; (i) has there been an evaluation of how many jobs will be created by this strategy, if yes, (i) how many jobs are expected to be created and for what duration, (ii) who conducted this evaluation, (iii) have the job creation projections been independently verified, and, if yes, ...

(Return tabled) Question No. 826 Ms. Olivia Chow: With regard to government resources allocated to research into sideguards on trucks: (a) listed annually for fiscal years 2006 to 2012, what are the resources allocated for researching, collecting, analyzing and evaluating data, broken down by (i) hours allocated, (ii) expenditures, including but not limited to personnel costs, fees, and research investments; (b) what are the (i) rationale, (ii) costs, (iii) planning and exact timelines for Phase II and Phase III of the National Research Council-conducted research work, with specific details about completion dates of the research work fo ...[+++]r each phase, draft completion dates, report approval and planned and actual publication dates; (c) what are the planned and budgeted time and resource allocation for truck-sideguard-related research work for the fiscal years 2011-2012, 2012-2013, 2013-2014, and 2014-2015, including information on the funding source(s) or, in the case of an absence of detailed planning, the rationale and decision-making process; (d) what are the planning and decision-making processes for truck-sideguard-related research and policy work in terms of (i) involved entities, including but not limited to Transport Canada, internal and external government institutions, departments, groups, sub-groups, and individuals, (ii) projected and actual timelines, (iii) involvement of external entities including consultants, experts, research organizations, lawyers, lobbyists, industry associations, companies and civic groups and individuals, broken down by name, dates of involvement, duration of involvement, nature and scope of involvement, involvement in outcomes and results; and (e) from 2006 to the present, who are the external entities involved in any part of the research or decision-making process, including consultants, experts, research organizations, lawyers, lobbyists, industry associations, companies and civic groups and other individuals, broken down b ...